Overview of Osteoporosis

Osteoporosis is a chronic skeletal disease characterized by decreased bone density and microarchitectural deterioration of bone tissue, leading to fragile bones and an increased risk of fractures. This condition is extremely common among the elderly worldwide, especially in postmenopausal women, but men can also be affected. Osteoporosis often develops silently without symptoms until a fracture occurs, hence it is called the "silent epidemic".

According to the World Health Organization, approximately 1 in 3 women and 1 in 5 men over the age of 70 may suffer fractures related to osteoporosis. Early diagnosis and intervention can significantly reduce fracture risk, but public awareness remains insufficient. This article will detail the causes, symptoms, diagnostic methods, and prevention strategies for osteoporosis to help readers develop a comprehensive understanding of the disease.

Causes and Risk Factors

The development of osteoporosis involves complex physiological mechanisms and multiple risk factors. Bone metabolism in the human skeleton maintains a dynamic balance between "bone formation" and "bone resorption." When osteoclast activity exceeds osteoblast activity, bone density gradually decreases. As age increases, the risk of this balance being disrupted rises, especially in women after menopause due to a sharp decline in estrogen, which accelerates bone loss at a rate of 1-5% per year.

Genetic factors play a key role in the pathogenesis, with a positive family history increasing risk by 1.5 to 2 times. Other risk factors include:

  • Gender: Women have a fourfold higher risk than men due to hormonal changes
  • Nutritional deficiencies: Low calcium intake or vitamin D deficiency
  • Lifestyle: Long-term lack of exercise, excessive alcohol or caffeine consumption
  • Diseases and medications: Hyperthyroidism, long-term steroid use, etc.

Recent studies indicate that cytokine imbalance and oxidative stress are also key pathogenic mechanisms. Decreased activity of bone morphogenetic proteins (BMPs) secreted by osteoblasts, combined with overactive RANKL molecules promoting osteoclast differentiation, leads to excessive bone resorption. Changes in these biological markers have become targets for novel therapies.

Symptoms

The most characteristic symptom of osteoporosis is "asymptomatic progression." Early patients may only experience mild back pain or gradual height loss. When bone density decreases to a certain extent, minor external forces such as bending or coughing may trigger vertebral compression fractures, resulting in kyphosis (spinal curvature) or height reduction of more than 4 centimeters. Typical symptoms include:

  • Unexplained chronic back pain, especially worsened by load-bearing
  • Height shortening accompanied by spinal scoliosis
  • Fractures of the wrist, hip, or vertebrae after minor trauma

Clinically, about half of the patients are not diagnosed before their first fracture. Pain from vertebral fractures may be mechanical, worsening with activity and relieved at rest. Severe cases may present with nerve compression symptoms such as sciatica. It is noteworthy that symptom presentation may differ among populations; Asian patients often have an increased fracture risk even before reaching diagnostic bone density thresholds due to insufficient nutrient intake.

Diagnosis

The diagnosis of osteoporosis primarily relies on bone mineral density testing and fracture risk assessment tools. Dual-energy X-ray absorptiometry (DEXA) is the internationally recognized diagnostic standard, with T-scores used to evaluate bone density: a T-score below -2.5 standard deviations indicates osteoporosis. Additionally, the Fracture Risk Assessment Tool (FRAX) integrates clinical risk factors to predict the 10-year probability of major osteoporotic and hip fractures.

Imaging examinations: X-rays can only detect abnormalities after bone loss exceeds 30%, thus are mainly used to confirm fractures rather than early diagnosis. Quantitative ultrasound (QUS) serves as a screening tool but is less precise than DEXA. Blood tests can assess calcium, phosphorus, vitamin D levels, and parathyroid hormone to differentiate primary from secondary osteoporosis.

The diagnostic process usually involves three stages: first, taking a medical history to assess fracture history and risk factors; second, performing bone density measurement; and third, integrating clinical data to develop a personalized management plan. For suspected severe cases, additional imaging such as vertebral fracture CT scans or MRI may be required to exclude other skeletal diseases.

Treatment Options

The goal of osteoporosis treatment is to increase bone density, strengthen bone quality, and prevent fractures. Pharmacological treatments are divided into bone formation stimulants and anti-resorptive agents. Common medications include:

  • Bisphosphonates (e.g., alendronate) to inhibit osteoclast activity
  • Parathyroid hormone analogs (e.g., teriparatide) to promote new bone formation
  • Selective estrogen receptor modulators (SERMs) to mimic hormonal protective effects

Non-pharmacological treatments emphasize nutritional management. It is recommended to intake 1200-1500 mg of calcium and 800-1000 IU of vitamin D daily, supplemented if necessary. Weight-bearing exercises such as walking and dancing stimulate bone formation, while balance training reduces fall risk. For severe osteoporosis, physical therapists may design personalized exercise programs to strengthen muscle support.

Emerging therapies include monoclonal anti-RANKL antibodies (e.g., denosumab), which work by blocking osteoclast activation, administered via subcutaneous injection every six months. Treatment plans should be tailored based on age, fracture history, and comorbidities, with combination therapies used for optimal results.

Prevention

Prevention of osteoporosis should start in adolescence, as peak bone mass determines future bone loss tolerance. It is advised to accumulate sufficient bone mass before age 20, and maintain bone health afterward through the following measures:

  1. Daily intake of dairy products, dark green vegetables, and other natural calcium sources
  2. Regular weight-bearing and resistance exercises
  3. Avoiding smoking and excessive alcohol consumption

Middle-aged and elderly populations should undergo regular bone density screening, especially postmenopausal women or those with a family history. Home environment modifications such as removing rugs and increasing lighting can reduce fall-related fractures. Recent research suggests that vitamin K2 and plant estrogens may help maintain bone collagen quality, but should be used under medical supervision.

Prevention strategies should integrate diet, exercise, and medical monitoring. For example, women over 65 should have DEXA scans every two years, with annual screening for high-risk groups. Community health promotion should emphasize "lifecycle management of bone health," maintaining skeletal health from childhood to old age.

When Should You See a Doctor?

Seek immediate medical evaluation if you experience:

  • Unexplained persistent back pain, especially with activity limitation
  • Height reduction exceeding 2 centimeters
  • Fractures after minor trauma (e.g., wrist fracture from a fall from standing height)

Even without obvious symptoms, individuals who meet the following criteria should undergo professional assessment:

  • Over 65 years old or postmenopausal women
  • Family history or early menopause
  • Long-term use of steroids or other bone resorption-promoting medications

Early diagnosis can be achieved through bone density screening. It is recommended that high-risk individuals undergo proactive medical evaluation even if asymptomatic. Doctors may suggest follow-up DEXA scans every 1-2 years and assess fracture risk scores to develop personalized prevention plans.

 

Frequently Asked Questions

What types of exercise are safest and most effective for osteoporosis patients?

Weight-bearing exercises such as walking, jogging, and resistance training can effectively stimulate bone formation, but high-impact activities should be avoided. Low-impact aerobic exercises (e.g., swimming, cycling) combined with strength training are recommended, preferably under the guidance of a physician or physical therapist to reduce fracture risk.

Can calcium tablets and vitamin D supplements completely replace dietary intake?

Supplements can compensate for dietary deficiencies, but calcium from natural foods (such as dairy and green leafy vegetables) has higher absorption rates and provides more comprehensive nutrition when combined with other nutrients. It is advisable to consume the recommended daily amount of calcium (about 1000-1200 mg for adults) and use supplements as needed under medical guidance to avoid excess, which can cause kidney stones and other side effects.

Are hormone therapies effective for osteoporosis besides medication?

Hormonal imbalances (such as estrogen deficiency) do accelerate bone loss, but hormone replacement therapy (HRT) must be carefully evaluated for risks and benefits. Physicians may recommend short-term use in women with severe osteoporosis, but long-term use can increase cardiovascular or breast cancer risks, requiring regular monitoring.

Can bone density recover to normal levels after diagnosis?

Bone density cannot fully return to pre-disease levels, but with medications (such as bisphosphonates) and healthy lifestyle changes, bone loss can be significantly slowed or even partially reversed. Early treatment and continuous monitoring are key to preventing fractures and worsening conditions.

Should people in their 30s start preventing osteoporosis?

Yes. Bone density peaks around age 30 and then gradually declines. It is important to actively build bone reserves from a young age. Recommendations include adequate calcium and vitamin D intake, regular weight-bearing exercise, and avoiding smoking and excessive alcohol to delay future bone loss.

Osteoporosis